Citations to this article
Colt A. Egelston, … , Yuan Yuan, Peter P. Lee
Published August 29, 2019
Citation Information: JCI Insight. 2019;4(19):e130000. https://doi.org/10.1172/jci.insight.130000.
Citation Information: JCI Insight. 2019;4(19):e130000. https://doi.org/10.1172/jci.insight.130000.
Abstract
CD8+ tumor-infiltrating lymphocytes (TILs) correlate with relapse-free survival (RFS) in most cancer types, including breast cancer. However, subset composition, functional status, and spatial location of CD8+ TILs in relation to RFS in human breast tumors remain unclear. Spatial tissue analysis via quantitative immunofluorescence showed that infiltration of CD8+ T cells into cancer islands was more significantly associated with RFS than CD8+ T cell infiltration into either tumor stroma or total tumor. Localization into cancer islands within tumors is mediated by expression of the integrin CD103, which is a marker for tissue-resident memory T cells (TRMs). Analysis of fresh tumor samples revealed that CD8+ TRMs are functionally similar to other CD8+ TILs, suggesting that the basis of their protective effect is their spatial distribution rather than functional differences. Indeed, CD103+ TRMs, as compared with CD103–CD8+ TILs, are enriched within cancer islands, and CD8+ TRM proximity to cancer cells drives the association of CD8+ TIL densities with RFS. Together, these findings reveal the importance of cancer island–localized CD8+ TRMs in surveillance of the breast tumor microenvironment and as a critical determinant of RFS in patients with breast cancer.
Authors
Colt A. Egelston, Christian Avalos, Travis Y. Tu, Anthony Rosario, Roger Wang, Shawn Solomon, Gayathri Srinivasan, Michael S. Nelson, Yinghui Huang, Min Hui Lim, Diana L. Simons, Ting-Fang He, John H. Yim, Laura Kruper, Joanne Mortimer, Susan Yost, Weihua Guo, Christopher Ruel, Paul H. Frankel, Yuan Yuan, Peter P. Lee
Citation information
Citations to this article (73)
| Title and authors | Publication | Year |
|---|---|---|
|
Spatial proximity of CD8+ T cells to tumor cells predicts neoadjuvant therapy efficacy in breast cancer
Liang H, Huang J, Li H, He W, Ao X, Xie Z, Chen Y, Lv Z, zhang L, Zhong Y, Tan X, Han G, Zhou J, Qiu N, Jiang M, Xia H, Zhan Y, Jiao L, Ma J, Radisky D, Huang J, Zhang X |
NPJ Breast Cancer | 2025 |
|
Immune characteristics and clinical significance of peripheral blood lymphocytes in breast cancer.
Gao H, Ouyang D, Guan X, Xu J, Chen Q, Zeng L, Pang J, Zou Q, Qian K, Yi W |
BMC Cancer | 2024 |
|
The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer
Dou T, Li J, Zhang Y, Pei W, Zhang B, Wang B, Wang Y, Jia H |
Frontiers in immunology | 2024 |
|
Guardians and Mediators of Metastasis: Exploring T Lymphocytes, Myeloid-Derived Suppressor Cells, and Tumor-Associated Macrophages in the Breast Cancer Microenvironment
Ruocco MR, Gisonna A, Acampora V, D\u2019Agostino A, Carrese B, Santoro J, Venuta A, Nasso R, Rocco N, Russo D, Cavaliere A, Altobelli GG, Masone S, Avagliano A, Arcucci A, Fiume G |
International journal of molecular sciences | 2024 |
|
The potential role of CD8+ cytotoxic T lymphocytes and one branch connected with tissue-resident memory in non-luminal breast cancer
Zhao Z, Ma X, Cai Z |
PeerJ | 2024 |
|
The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy.
Nicolini A, Ferrari P, Silvestri R, Gemignani F, Nicolini A, Ferrari P, Silvestri R, Gemignani F |
2024 | |
|
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer
Jahangir CA, Page DB, Broeckx G, Gonzalez CA, Burke C, Murphy C, Reis-Filho JS, Ly A, Harms PW, Gupta RR, Vieth M, Hida AI, Kahila M, Kos Z, van Diest PJ, Verbandt S, Thagaard J, Khiroya R, Abduljabbar K, Haab GA, Acs B, Adams S, Almeida JS, Alvarado-Cabrero I, Azmoudeh-Ardalan F, Badve S, Baharun NB, Bellolio ER, Bheemaraju V, Blenman KR, Fujimoto LB, Burgues O, Chardas A, Cheang MC, Ciompi F, Cooper LA, Coosemans A, Corredor G, Portela FL, Deman F, Demaria S, Dudgeon SN, Elghazawy M, Fernandez-Martín C, Fineberg S, Fox SB, Giltnane JM, Gnjatic S, Gonzalez-Ericsson PI, Grigoriadis A, Halama N, Hanna MG, Harbhajanka A, Hart SN, Hartman J, Hewitt S, Horlings HM, Husain Z, Irshad S, Janssen EA, Kataoka TR, Kawaguchi K, Khramtsov AI, Kiraz U, Kirtani P, Kodach LL, Korski K, Akturk G, Scott E, Kovács A, Lænkholm AV, Lang-Schwarz C, Larsimont D, Lennerz JK, Lerousseau M, Li X, Madabhushi A, Maley SK, Narasimhamurthy VM, Marks DK, McDonald ES, Mehrotra R, Michiels S, Kharidehal D, Minhas FU, Mittal S, Moore DA, Mushtaq S, Nighat H, Papathomas T, Penault-Llorca F, Perera RD, Pinard CJ, Pinto-Cardenas JC, Pruneri G, Pusztai L, Rajpoot NM, Rapoport BL, Rau TT, Ribeiro JM, Rimm D, Vincent-Salomon A, Saltz J, Sayed S, Hytopoulos E, Mahon S, Siziopikou KP, Sotiriou C, Stenzinger A, Sughayer MA, Sur D, Symmans F, Tanaka S, Taxter T, Tejpar S, Teuwen J, Thompson EA, Tramm T, Tran WT, van der Laak J, Verghese GE, Viale G, Wahab N, Walter T, Waumans Y, Wen HY, Yang W, Yuan Y, Bartlett J, Loibl S, Denkert C, Savas P, Loi S, Stovgaard ES, Salgado R, Gallagher WM, Rahman A |
The Journal of Pathology | 2024 |
|
Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncology
Mi H, Sivagnanam S, Ho WJ, Zhang S, Bergman D, Deshpande A, Baras AS, Jaffee EM, Coussens LM, Fertig EJ, Popel AS |
Briefings in Bioinformatics | 2024 |
|
Immunologic Mechanisms of BCc1 Nanomedicine Synthesized by Nanochelating Technology in Breast Tumor-bearing Mice: Immunomodulation and Tumor Suppression.
Karimi P, Fakharzadeh S, Kalanaky S, Hafizi M, Hashemi M, Mahdavi M, Nazaran MH |
Anti-cancer agents in medicinal chemistry | 2024 |
|
Integrating immunotherapy with conventional treatment regime for breast cancer patients- an amalgamation of armamentarium
Nandi D, Sharma D |
Frontiers in Immunology | 2024 |
|
Tissue-resident T cells in Clinical Response and Immune-related Adverse Events of Immune Checkpoint Blockade
Zhao Y, Wucherpfennig KW |
Clinical cancer research : an official journal of the American Association for Cancer Research | 2024 |
|
Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similar
Mutka M, Joensuu K, Eray M, Heikkilä P |
Diagnostic Pathology | 2023 |
|
Nasal Tumor Vaccination Protects against Lung Tumor Development by Induction of Resident Effector and Memory Anti-Tumor Immune Responses
Donkor M, Choe J, Reid DM, Quinn B, Pulse M, Ranjan A, Chaudhary P, Jones HP |
Pharmaceutics | 2023 |
|
Localization, tissue biology and T cell state - implications for cancer immunotherapy.
Schenkel JM, Pauken KE |
Nature reviews. Immunology | 2023 |
|
Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich Invasive Breast Carcinoma of No Special Type.
Zhao Y, Huang T, Jin X, Gong XM, Lu YZ |
2023 | |
|
Immune mechanisms shape the clonal landscape during early progression of prostate cancer
Tshering LF, Luo F, Russ S, Szenk M, Rubel D, Tutuska K, Rail JG, Balázsi G, Shen MM, Talos F |
Developmental Cell | 2023 |
|
Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy
Damei I, Trickovic T, Mami-Chouaib F, Corgnac S |
Frontiers in immunology | 2023 |
|
The spread of interferon-γ in melanomas is highly spatially confined, driving nongenetic variability in tumor cells
Centofanti E, Wang C, Iyer S, Krichevsky O, Oyler-Yaniv A, Oyler-Yaniv J |
Proceedings of the National Academy of Sciences | 2023 |
|
Memory T Cells in the Immunoprevention of Cancer: A Switch from Therapeutic to Prophylactic Approaches.
Mittra S, Harding SM, Kaech SM |
Journal of immunology (Baltimore, Md. : 1950) | 2023 |
|
The Possible Role of Anti- and Protumor-Infiltrating Lymphocytes in Pathologic Complete Response in Early Breast Cancer Patients Treated with Neoadjuvant Systemic Therapy
Geršak K, Geršak BM, Gazić B, Klevišar Ivančič A, Drev P, Ružić Gorenjec N, Grašič Kuhar C |
Cancers | 2023 |
|
Egress of resident memory T cells from tissue with neoadjuvant immunotherapy: implications for systemic anti-tumor immunity
Rainey MA, Allen CT, Craveiro M |
Oral Oncology | 2023 |
|
Delineating spatial cell-cell interactions in the solid tumour microenvironment through the lens of highly multiplexed imaging
Cohn DE, Forder A, Marshall EA, Vucic EA, Stewart GL, Noureddine K, Lockwood WW, MacAulay CE, Guillaud M, Lam WL |
Frontiers in immunology | 2023 |
|
Stromal localization of inactive CD8(+) T cells in metastatic mismatch repair deficient colorectal cancer.
Küçükköse E, Baars MJD, Amini M, Schraa SJ, Floor E, Bol GM, Borel Rinkes IHM, Roodhart JML, Koopman M, Laoukili J, Kranenburg O, Vercoulen Y |
British Journal of Cancer | 2023 |
|
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.
Oliveira G, Egloff AM, Afeyan AB, Wolff JO, Zeng Z, Chernock RD, Zhou L, Messier C, Lizotte P, Pfaff KL, Stromhaug K, Penter L, Haddad RI, Hanna GJ, Schoenfeld JD, Goguen LA, Annino DJ, Jo V, Oppelt P, Pipkorn P, Jackson R, Puram SV, Paniello RC, Rich JT, Webb J, Zevallos JP, Mansour M, Fu J, Dunn GP, Rodig SJ, Ley J, Morris LGT, Dunn L, Paweletz CP, Kallogjeri D, Piccirillo JF, Adkins DR, Wu CJ, Uppaluri R |
Science Immunology | 2023 |
|
Tumor infiltrating exhausted CD8+ T cells dictate reduced survival in pre-menopausal estrogen receptor-positive breast cancer
Colt A. Egelston, Weihua Guo, Jiayi Tan, Christian Avalos, Diana L Simons, Min Hui Lim, Yinghui J Huang, Michael S. Nelson, Arnab Chowdhury, Daniel B Schmolze, John Yim, Laura Kruper, Laleh Melstrom, Kim Margolin, Joanne E Mortimer, Yuan Yuan, James Waisman, Peter P. Lee |
JCI Insight | 2022 |
|
Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer
I Nederlof, S Hajizadeh, F Sobhani, S Raza, K AbdulJabbar, R Harkes, M van de Vijver, R Salgado, C Desmedt, M Kok, Y Yuan, H Horlings |
npj Breast Cancer | 2022 |
|
cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment
S Mishra, M Charan, R Shukla, P Agarwal, S Misri, A Verma, D Ahirwar, J Siddiqui, K Kaul, N Sahu, K Vyas, A Garg, A Khan, W Miles, J Song, N Bhutani, R Ganju |
Journal of Experimental & Clinical Cancer Research | 2022 |
|
Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution
E Tzoras, I Zerdes, N Tsiknakis, G Manikis, A Mezheyeuski, J Bergh, A Matikas, T Foukakis |
Cancers | 2022 |
|
LLT1-CD161 Interaction in Cancer: Promises and Challenges
V Braud, A Meghraoui-Kheddar, R Elaldi, L Petti, C Germain, F Anjuère |
Frontiers in immunology | 2022 |
|
Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer
B Maisel, M Yi, A Peck, Y Sun, J Hooke, A Kovatich, C Shriver, H Hu, M Nevalainen, T Tanaka, N Simone, L Wang, H Rui, I Chervoneva |
Cancers | 2022 |
|
Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma
N Zakeri, A Hall, L Swadling, L Pallett, N Schmidt, M Diniz, S Kucykowicz, O Amin, A Gander, M Pinzani, B Davidson, A Quaglia, M Maini |
Nature Communications | 2022 |
|
Association of CD103+ T cell infiltration with overall survival in solid tumors of the digestive tract and its potential in anti-PD-1 treatment: A review and meta-analysis
W Wei, Y Ding, J He, J Wu |
Biomedical Papers | 2022 |
|
Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer
Čeprnja T, Mrklić I, Perić Balja M, Marušić Z, Blažićević V, Spagnoli GC, Juretić A, Čapkun V, Tečić Vuger A, Vrdoljak E, Tomić S |
Journal of Personalized Medicine | 2022 |
|
An activation to memory differentiation trajectory of tumor infiltrating lymphocytes informs metastatic melanoma outcomes
Jaiswal A, Verma A, Dannenfelser R, Melssen M, Tirosh I, Izar B, Kim TG, Nirschl CJ, Devi KS, Olson WC Jr, Slingluff CL Jr, Engelhard VH, Garraway L, Regev A, Minkis K, Yoon CH, Troyanskaya O, Elemento O, Suárez-Fariñas M, Anandasabapathy N |
Cancer Cell | 2022 |
|
Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response
Rapoport BL, Nayler S, Mlecnik B, Smit T, Heyman L, Bouquet I, Martel M, Galon J, Benn CA, Anderson R |
Cancers | 2022 |
|
Exploration of Novel Immunological Terms in Lung Cancer With Large Populations: Implications for Immunotherapy
Yao Y, Wang J, Yang F, Gao W |
Frontiers in immunology | 2022 |
|
Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes.
Duhen T, Gough MJ, Leidner RS, Stanton SE |
2022 | |
|
Subtype-Specific Tumour Immune Microenvironment in Risk of Recurrence of Ductal Carcinoma In Situ: Prognostic Value of HER2
Solek J, Chrzanowski J, Cieslak A, Zielinska A, Piasecka D, Braun M, Sadej R, Romanska HM |
Biomedicines | 2022 |
|
Clever-1 positive macrophages in breast cancer.
Mutka M, Virtakoivu R, Joensuu K, Hollmén M, Heikkilä P |
Breast Cancer Research and Treatment | 2022 |
|
Tumor immune microenvironment changes by multiplex immunofluorescence staining in a pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a hereditary BRCA mutation
Kumar T, Hobbs E, Yang F, Chang JT, Contreras A, Cuentas ER, Garber H, Lee S, Lu Y, Scoggins ME, Adrada BE, Whitman GJ, Arun BK, Mittendorf EA, Litton JK |
Clinical cancer research | 2022 |
|
The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors
Tosi A, Parisatto B, Menegaldo A, Spinato G, Guido M, Del Mistro A, Bussani R, Zanconati F, Tofanelli M, Tirelli G, Boscolo-Rizzo P, Rosato A |
Journal of experimental & clinical cancer research : CR | 2022 |
|
Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood
Wall I, Boulat V, Shah A, Blenman KR, Wu Y, Alberts E, Calado DP, Salgado R, Grigoriadis A |
Cancers | 2022 |
|
Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer
Massa D, Tosi A, Rosato A, Guarneri V, Dieci MV |
Cancers | 2022 |
|
Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer
Jungles KM, Holcomb EA, Pearson AN, Jungles KR, Bishop CR, Pierce LJ, Green MD, Speers CW |
Frontiers in Oncology | 2022 |
|
Human T lymphocytes at tumor sites
Notarbartolo S, Abrignani S |
Seminars in Immunopathology | 2022 |
|
Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell–Cell Interactions That Predict Immunotherapy Response
Antoranz A, Van Herck Y, Bolognesi MM, Lynch SM, Rahman A, Gallagher WM, Boecxstaens V, Marine JC, Cattoretti G, van den Oord JJ, De Smet F, Bechter O, Bosisio FM |
Cancer research | 2022 |
|
Biological and molecular studies on specific immune cells treated with checkpoint inhibitors for the thera-personal approach of breast cancer patients (ex-vivo study)
EL-HOUSEINI ME, ARAFAT MS, EL-HUSSEINY AM, KASEM IM, KAMEL MM, EL-HABASHY AH, KHAFAGY MM, RADWAN EM, HELAL MH, ABDELLATEIF MS |
Oncology research | 2022 |
|
Hypoxia-inducible factor activity promotes anti-tumor effector function and tissue residency by CD8+ T cells
Ilkka Liikanen, Colette Lauhan, Sara Quon, Kyla Omilusik, Anthony T. Phan, Laura Barceló-Bartroli, John Goulding, Amir Ferry, Joyce Chen, James P Scott-Browne, Jason T. Yustein, Nicole E Scharping, Deborah A. Witherden, Ananda W. Goldrath |
Journal of Clinical Investigation | 2021 |
|
Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
MA Nelson, W Ngamcherdtrakul, SW Luoh, W Yantasee |
Cancer and Metastasis Reviews | 2021 |
|
The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy
S Asiry, G Kim, PS Filippou, LR Sanchez, D Entenberg, DK Marks, MH Oktay, GS Karagiannis |
Frontiers in immunology | 2021 |
|
Promises and challenges of adoptive T-cell therapies for solid tumours
M Morotti, A Albukhari, A Alsaadi, M Artibani, JD Brenton, SM Curbishley, T Dong, ML Dustin, Z Hu, N McGranahan, ML Miller, L Santana-Gonzalez, LW Seymour, T Shi, PV Loo, C Yau, H White, N Wietek, DN Church, DC Wedge, AA Ahmed |
British Journal of Cancer | 2021 |
|
The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors
TC Blair, AF Alice, L Zebertavage, MR Crittenden, MJ Gough |
Frontiers in Oncology | 2021 |
|
Engineering Vaccines for Tissue‐Resident Memory T Cells
FC Knight, JT Wilson |
2021 | |
|
CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer
PT de Lara, H Castañón, M Vermeer, N Núñez, K Silina, B Sobottka, J Urdinez, V Cecconi, H Yagita, FM Attar, S Hiltbrunner, I Glarner, H Moch, S Tugues, B Becher, M van den Broek |
Nature Communications | 2021 |
|
Distribution, phenotype, functional and clinical relevance of CD8+CD103+ tissue-resident memory T cells in human gastric cancer
Y Shen, X Li, Y Li, Z Shan, Y Zhao, P Cheng, Z Zhao, J Zhang, W Chen, Y Zhuang, D Ma, Q Zou, Y Qiu, L Peng |
Cancer Immunology, Immunotherapy | 2021 |
|
A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer
I Nederlof, HM Horlings, C Curtis, M Kok |
Cancers | 2021 |
|
The Potential of Tissue-Resident Memory T Cells for Adoptive Immunotherapy against Cancer
A Beumer-Chuwonpad, RL Taggenbrock, TA Ngo, K van Gisbergen |
Cells | 2021 |
|
Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy
W Zhang |
Purinergic Signalling | 2021 |
|
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
F Li, C Li, X Cai, Z Xie, L Zhou, B Cheng, R Zhong, S Xiong, J Li, Z Chen, Z Yu, J He, W Liang |
2021 | |
|
Tissue-resident memory T cells in tumor immunity and immunotherapy
K Okła, DL Farber, W Zou |
Journal of Experimental Medicine | 2021 |
|
Cytotoxic CD8+ T cells and tissue resident memory cells in colorectal cancer based on microsatellite instability and BRAF status
JW Toh, AL Ferguson, KJ Spring, H Mahajan, U Palendira |
World journal of clinical oncology | 2021 |
|
Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high‐grade serous ovarian cancer
G Zhang, Q Xu, X Zhang, M Yang, Y Wang, M He, J Lu, H Liu |
Cancer Medicine | 2021 |
|
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
C Krishna, RG DiNatale, F Kuo, RM Srivastava, L Vuong, D Chowell, S Gupta, C Vanderbilt, TA Purohit, M Liu, E Kansler, BG Nixon, YB Chen, V Makarov, KA Blum, K Attalla, S Weng, ML Salmans, M Golkaram, L Liu, S Zhang, R Vijayaraghavan, T Pawlowski, V Reuter, MI Carlo, MH Voss, J Coleman, P Russo, RJ Motzer, MO Li, CS Leslie, TA Chan, AA Hakimi |
Cancer Cell | 2021 |
|
A novel role for an old target: CD45 for breast cancer immunotherapy
A Raiter, O Zlotnik, J Lipovetsky, S Mugami, S Dar, I Lubin, E Sharon, CJ Cohen, R Yerushalmi |
OncoImmunology | 2021 |
|
Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition
LC Pomatto-Watson, M Bodogai, O Bosompra, J Kato, S Wong, M Carpenter, E Duregon, D Chowdhury, P Krishna, S Ng, E Ragonnaud, R Salgado, PG Ericsson, A Diaz-Ruiz, M Bernier, NL Price, A Biragyn, VD Longo, R de Cabo |
Nature Communications | 2021 |
|
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
F Manfredi, BC Cianciotti, A Potenza, E Tassi, M Noviello, A Biondi, F Ciceri, C Bonini, E Ruggiero |
Frontiers in immunology | 2020 |
|
Breast Cancer Heterogeneity and Response to Novel Therapeutics
M Baliu-Piqué, A Pandiella, A Ocana |
Cancers | 2020 |
|
Memory CD8+ T cell responses to cancer
J Han, N Khatwani, TG Searles, MJ Turk, CV Angeles |
Seminars in Immunology | 2020 |
|
Tissue-resident memory-like T cells in tumor immunity: Clinical implications
MV Dhodapkar, KM Dhodapkar |
Seminars in Immunology | 2020 |
|
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
JK Khalsa, N Cheng, J Keegan, A Chaudry, J Driver, WL Bi, J Lederer, K Shah |
Nature Communications | 2020 |
|
Resident Memory T Cells and Their Effect on Cancer
DJ Craig, JF Creeden, KR Einloth, CE Gillman, L Stanbery, D Hamouda, G Edelman, L Dworkin, JJ Nemunaitis |
Human vaccines | 2020 |
|
Racial differences in CD8+ T cell infiltration in breast tumors from Black and White women
Y Abdou, K Attwood, TY Cheng, S Yao, EV Bandera, GR Zirpoli, RP Ondracek, L Stein, W Bshara, T Khoury, CB Ambrosone, AR Omilian |
Breast Cancer Research | 2020 |
|
The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer
SL Goff, DN Danforth |
Clinical Breast Cancer | 2020 |
